Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19).

Details

Language :

English

ISSN :

1437-7772

Volume :

26

Issue :

7

Database :

MEDLINE

Journal :

International journal of clinical oncology

Accession number :

34043103

Full Text :

https://doi.org/10.1007/s10147-021-01940-w